Diagnosis of antiphospholipid syndrome (APS) requires the presence of a clinical criterion
(thrombosis and/or pregnancy morbidity), combined with persistently circulating …

Since the beginning of the Coronavirus disease (COVID)-19 pandemic in December 2019,
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new virus discovered
in December 2019 that causes coronavirus disease 19 (COVID-19) and various …

Background Thrombosis is a unique complication of coronavirus disease 2019 (COVID-19).
Although antiphospholipid antibodies (aPL) are detected in COVID-19 patients, their clinical …

Background The significance of antiphospholipid antibodies (aPL) in COVID-19 remains
uncertain. Objectives We determined whether aPL are associated with COVID-19 and/or …

Antiphospholipid syndrome (APS) is a chronic autoimmune disease involving vascular
thrombosis and/or obstetric morbidity and persistent antibodies to phospholipids or certain …

Infection with SARS-CoV-2 initiates an immune-hemostatic response. While both systems
are intimately connected and necessary for an efficient immune response to contain the …

Publikacja / Publication Temporal changes of hemostatic activity in patients hospitalized for
COVID-19 : a prospective observati Page 1 UNIWERSYTET JAGIELLOŃSKI COLLEGIUM …

Objective Lupus anticoagulant (LA) are commonly detected during SARS‐CoV‐2 infection.
However, the relationship between LA and clinical significance is still unclear. Methods A …

Materials and Methods: This case-control study examined anti-phospholipid antibodies
(including lupus anticoagulant, anti-cardiolipin antibody, and anti-beta-2 glycoprotein …